Gustavo Denegri is an Italian businessman who has achieved success in multiple industries. After training as a chemist, he founded Gruppo Pro-Ind and merged it with Piaggio, a manufacturer of two-wheel vehicles. He grew Piaggio into a $1.2 billion company before selling his majority stake and moving to private equity. His biggest bet was DiaSorin, a biotech firm he acquired from Standard Companies in 2000. Today, DiaSorin is a global leader in in vitro diagnostics with revenue of over $500 million. In 2016, the U.S. Department of Health and Human Services awarded DiaSorin $2.6 million to develop a test for the Zika virus. Denegri's son Michele now runs Investimenti e Partecipazioni, a diverse portfolio of investments including medical technology, real estate, and TV production.
Gustavo Denegri is a member of Healthcare
Age, Biography and Wiki
Birth Year |
1937 |
Birth Place |
torino, Italy, Italy |
Age
|
86 YEARS OLD |
Residence |
Turin, Italy |
Alma mater |
University of Turin |
Known for |
owner of 44% of DiaSorin |
Title |
Chairman, DiaSorin |
Spouse(s) |
married |
Children |
2 |
💰 Net worth: $3.2 Billion (2024)
Gustavo Denegri, an entrepreneur and philanthropist known for his contributions in the healthcare sector in Italy, is estimated to have a net worth of $3.2 Billion by 2024. Denegri's wealth is a result of his successful ventures and investments in the healthcare industry, where he has made significant advancements in medical research and development. His dedication towards improving healthcare accessibility and quality has earned him a prominent position in the field, making him a well-respected figure both domestically and internationally. With his considerable net worth, Gustavo Denegri continues to make substantial investments and initiatives to further revolutionize the healthcare landscape and positively impact the lives of countless individuals.
Some Gustavo Denegri images